Glioblastoma (GBM), also referred to as World Health Organization grade IV astrocytoma, is one of the most vascular-rich tumors and is characterized by vascular proliferation in response to abundant vascular endothelial growth factor (VEGF) which is produced by tumor cells [1–3]. Here, VEGFA is linked to neoplasm.